AUSTIN, Texas--(BUSINESS WIRE)--The Cancer Prevention and Research Institute of Texas (CPRIT) today announced a strategic partnership agreement with the Swiss-based healthcare company Roche (SIX: RO, ROG, OTCQX: RHHBY) to accelerate the development of promising oncology-related cancer research projects in Texas. Under the terms of the agreement, CPRIT and Roche will collaborate to identify ventures and technologies from academia and early stage projects in Texas that have the potential to strengthen Roche’s R&D portfolio.
